Pharma Focus Europe

News

The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.

Roche Has Concluded a Definitive Agreement to Purchase Lumiradx's Point of Care Technology, Bringing Together Various Diagnostic Modalities on a Unified Platform

Saturday, December 30, 2023

Roche has formally entered into a definitive agreement to acquire specific components of the LumiraDx group NASDAQ GS LMDX related to LumiraDxs Point of Care technology

Nectin Therapeutics Advances Current Clinical Trial and Expands Trial Sites to Include Israel

Wednesday, December 27, 2023

Nectin Therapeutics Ltd a biotechnology company focusing on the development of targeted immunotherapies to overcome resistance to approved immune oncology treatments has made notable progress in its Phase clinical trial

European Commission Approves Marketing Authorization for Vueway® (Gadopiclenol)

Saturday, December 23, 2023

Bracco Imaging SpA has obtained marketing approval from the European Commission for Vueway a new contrast agent for magnetic resonance imaging The approval backed by the Committee

Ono and EVQLV Collaborate to Utilize AI-Driven Antibody Design Engine for the Development of Novel Antibody Drugs Targeting Multiple Pathways

Friday, December 22, 2023

Ono Pharmaceutical Co Ltd recently announced a collaborative agreement with EVQLV INC The collaboration is focused on the development of innovative antibody drugs through the generation of novel antibodies

Orphan Drug Designation for NS-089/NCNP-02 in the Treatment of Duchenne Muscular Dystrophy Granted by the European Commission

Friday, December 22, 2023

NS Pharma Inc a subsidiary of Nippon Shinyaku Co Ltd has been granted orphan drug designation by the European Commission for NSNCNP on December This drug is currently in development

Rentschler Biopharma Announces a Major Client Project for Its Newly Established Facility in Milford, Massachusetts, USA

Thursday, December 21, 2023

Rentschler Biopharma SE a leading global contract development and manufacturing organization specializing in biopharmaceuticals has revealed a significant development for its newly established Rentschler Biopharma Manufacturing Center

European Commission Revokes Generic Marketing Permissions for Dimethyl Fumarate (DMF), Including Dimethyl Fumarate Neuraxpharm

Thursday, December 21, 2023

Neuraxpharm Group a leading European pharmaceutical company specializing in the treatment of central nervous system disorders has been informed by the European Commission that it will revoke all centrally granted

Infinimmune and Grid Therapeutics Have Joined Forces to Conduct Extensive B Cell Deep Sequencing for the Purpose of Advancing Drug Discovery in the Field of Oncology

Wednesday, December 20, 2023

Infinimmune a biotechnology company specializing in novel methods for antibody drug discovery and development has recently entered into a collaboration with Grid Therapeutics a clinicalstage biotechnology

Inxmed and Escugen Have Established a Licensing Agreement to Advance the Development of Next-generation ADCS

Wednesday, December 20, 2023

In a recent collaborative venture InxMed a clinicalstage biotechnology firm specializing in groundbreaking therapies for drug resistance and Escugen a clinicalstage antibodydrug conjugate

Charles River and Vertex Pharmaceuticals Achieve Significant Milestone in Advancing Cell Therapy Manufacturing Collaboration

Tuesday, December 19, 2023

Charles River Laboratories International Inc has reached a significant milestone in its collaboration with Vertex Pharmaceuticals by obtaining regulatory approval for the production of CASGEVY

magazine-slider-img
Get instant
access to our latest e-book